Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Apis Therapeutics LLC
Profile last edited on: 8/9/2021      CAGE: 7X6A7      UEI: HJFTTHWQ97R4

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2011
First Award
2020
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

18 Blueberry Ridge Road
Setauket, NY 11733
   (631) 751-2063
   N/A
   N/A
Location: Single
Congr. District: 01
County: Suffolk

Public Profile

The most recent activity of the firm's principals organizes around the issue of "Dry eye" - a disease affecting 1 in 6 humans in the US and worldwide. Treatment of the disease using pharmacological agents is suboptimal and new agents are urgently needed. Apis personnel are proposing development a novel compound - phosphosulindac - described as potentially a highly effective and safe agent. Achieved results could pave the way towards completion of preclinical evaluation of phosphosulindac, a required step prior to its testing in humans.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$377,136
Phase II Dollars
$2,065,744
Total Awarded
$2,442,880

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $2,442,880
Project Title: Phosphosulindac for Dry Eye

Key People / Management

  Basil Rigas

Company News

There are no news available.